# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-103763
Filing Date
2025-04-29
Accepted
2025-04-29 16:05:26
Documents
15
Period of Report
2025-06-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d908829ddef14a.htm iXBRL | DEF 14A | 464339
3 | GRAPHIC | g908829g11s01.jpg | GRAPHIC | 33278
4 | GRAPHIC | g908829g11s02.jpg | GRAPHIC | 137854
5 | GRAPHIC | g908829g11s03.jpg | GRAPHIC | 233293
| Complete submission text file | 0001193125-25-103763.txt |  | 1806408

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | sepn-20241231.xsd | EX-101.SCH | 2498
17 | EXTRACTED XBRL INSTANCE DOCUMENT | d908829ddef14a_htm.xml | XML | 5099

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42382 | Film No.: 25887123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)